Day: August 9, 2022

Beat Q2 across all metrics. Gross Profit of $116.4M grew 16.1% and ex-TAC Gross Profit of $143.2M grew 22.5% over Q2 2021 (25.4% on a constant currency basis*) and 4.7% pro forma with Connexity** (7.1% on a constant currency basis*). GAAP Net Loss of $5.0M, Non-GAAP Net Income of $15.8M and Adjusted EBITDA of $34.2M. Maintaining full year guidance for ex-TAC Gross Profit, Gross Profit, Adjusted EBITDA and Non-GAAP Net Income.NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, today announced its results for the quarter ended June 30, 2022. “Our second quarter performance exceeded our high end of guidance and included ex-TAC gross profit growth of 22.5%. These impressive results, in a challenging macro environment,...

Q2 2022 GMV Increased 30% Year-Over-YearQ2 2022 Total Revenue Increased 47% Year-Over-YearQ2 2022 Net Income of $(53.2) million or (34.4)% of Total RevenueQ2 2022 Adjusted EBITDA of $(28.8) million or (18.7)% of Total Revenue SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today reported financial results for its second quarter ended June 30, 2022. The company reported solid top-line growth and significant operating expense leverage. Second quarter 2022 gross merchandise value (GMV) and total revenue and increased 30% and 47% respectively, compared to the second quarter of 2021. Second quarter 2022 net income was $(53.2) million or (34.4)% of total revenue. Second quarter 2022 Adjusted EBITDA loss improved to $(28.8) million...

HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the second quarter 2022. SECOND QUARTER 2022 SUMMARY (as compared to the second quarter 2021)Revenue of $35.9 million, 47.9% increase y/y Income from Continuing Operations of $0.5 million, including gain from insurance recoveries of $3.4 million and loss from Shipyard Division of $1.4 million Non-GAAP EBITDA from Continuing Operations of $1.8 million, including gain from insurance recoveries of $3.4 million and loss from Shipyard Division of $1.4 million Operating income for Services Division of $2.3 million, $1.0 million increase y/y Non-GAAP EBITDA for Services Division of $2.7 million, $1.3 million...

BOSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) — First Eagle Alternative Capital BDC, Inc. (NASDAQ: FCRD) (“First Eagle Alternative Capital BDC” or the “Company”), a direct lender to middle market companies, today announced financial results for its second fiscal quarter ended June 30, 2022. Additionally, the Company announced that its Board of Directors (the “Board”) has declared a third fiscal quarter 2022 dividend of $0.11 per share payable on September 30, 2022, to stockholders of record as of September 15, 2022. HIGHLIGHTS($ in millions, except per share amounts)  Portfolio results As of June 30, 2022  Total assets $386.1    Investment portfolio, at fair value $366.8    Net assets $158.7    Net asset value per share $5.30    Weighted average yield on investments   6.8 %    Quarter ended June 30, 2022 Quarter...

– Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced HER2 positive gastric and gastroesophageal junction (G/GEJ) cancers – – Completed a $30 million private placement by a single leading healthcare-focused institutional investor – – Named industry leader Diane Parks to Board of Directors – FLORHAM PARK, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today announced financial results for the second quarter ended June 30, 2022, and provided a corporate update. “We achieved another exciting milestone during the second quarter with the treatment of our first gastric cancer patient with CYNK-101, which we are evaluating...

SCOTTSDALE, Ariz., Aug. 09, 2022 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced financial results for the quarter ended June 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted)Q2 2022 Highlights and FY 2022 OutlookRevenue of $209.5 million increased $49.0 million or 31% compared to revenue of $160.5 million Total clinicians of 5,226 up 31%, a net increase of 237 in the second quarter Net loss of $68.7 million compared to net loss of $70.0 million, primarily driven by stock-based compensation expense of $57.5 million Adjusted EBITDA of positive $14.6 million compared to Adjusted EBITDA of positive $14.5 million Expecting full year 2022 revenue and Center Margin toward the bottom end of...